No leg leans either way.
Not held in any tracked 13F filing yet.
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| Company | Co-held by | Their position there |
|---|---|---|
| Kenvue IncKVUE | 15 funds | $1.6B |
| Nvidia CorpNVDA | 14 funds | $236.0B |
| Microsoft CorpMSFT | 14 funds | $225.1B |
| Broadcom IncAVGO | 14 funds | $94.8B |
| Alphabet Inc-CL CGOOG | 14 funds | $60.2B |
| JPMorgan Chase & CoJPM | 14 funds | $53.7B |
| Netflix IncNFLX | 14 funds | $33.7B |
| Eli Lilly & CoLLY | 14 funds | $33.6B |
| Oracle CorpORCL | 14 funds | $32.4B |
| Johnson & JohnsonJNJ | 14 funds | $28.9B |
| Costco Wholesale CorpCOST | 14 funds | $23.2B |
| Goldman Sachs Group IncGS | 14 funds | $20.4B |
Ranked by how many of ULYX's tracked holders also hold each name. The last column is those co-holders' combined reported position in that name, not in ULYX.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Sep 19, 2025 | Ben Volkow | Director | Sell (S) | 1K | $6K |
| Sep 18, 2025 | Ben Volkow | Director | Sell (S) | 800 | $3K |
| Aug 21, 2025 | Ben Volkow | Director | Sell (S) | 556 | $3K |
| Aug 20, 2025 | Ben Volkow | Director | Sell (S) | 800 | $4K |
| Aug 19, 2025 | Ben Volkow | Director | Sell (S) | 600 | $3K |
| Aug 18, 2025 | Ben Volkow | Director | Sell (S) | 300 | $1K |
| Jul 18, 2025 | Ben Volkow | Director | Sell (S) | 2K | $15K |
| Jun 18, 2025 | Ben Volkow | Director | Sell (S) | 2K | $9K |
| May 20, 2025 | Ben Volkow | Director | Sell (S) | 256 | $2K |
| May 19, 2025 | Ben Volkow | Director | Sell (S) | 2K | $14K |
| Apr 23, 2025 | Ben Volkow | Director | Sell (S) | 1K | $6K |
| Apr 22, 2025 | Ben Volkow | Director | Sell (S) | 600 | $3K |
No institutional, insider, or congressional activity for ULYX in the last 180 days.
Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.
Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive
| Source | Buying | Selling | Net |
|---|---|---|---|
13F funds Top 100 holders by value, passive included; the hero counts active managers only | 0 | 0 | – |
Insiders Form 4 open-market | 0 | 0 | $0 |
US House STOCK Act trades | 0 | 0 | $0 |
Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.
Connected entities for ULYX
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/ULYX/capital-change-brief"
Use Arkolith's capital_change_brief for ULYX. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + the live filing stream, joined for ULYX. Filings are public domain, sourced to SEC EDGAR.